CIBC Private Wealth Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

CIBC Private Wealth Group’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$598K	Hold	3,750	–	–	﹤0.01%	832
2025 Q3	$351K	Buy	+3,750	New	+$265K	﹤0.01%	969
2025 Q2	–	Sell	-1,000	Closed	-$37.6K	–	3214
2025 Q1	$37.6K	Sell	1,000 -3,750	-79%	-$320K	﹤0.01%	1736
2024 Q4	$458K	Sell	4,750 -1,000	-17%	-$118K	﹤0.01%	892
2024 Q3	$740K	Hold	5,750	–	–	﹤0.01%	758
2024 Q2	$661K	Buy	5,750 +3,750	+188%	+$401K	﹤0.01%	745
2024 Q1	$256K	Sell	2,000 -2,750	-58%	-$359K	﹤0.01%	1026
2023 Q4	$579K	Hold	4,750	–	–	﹤0.01%	761
2023 Q3	$362K	Buy	4,750 +1,250	+36%	+$128K	﹤0.01%	832
2023 Q2	$414K	Buy	3,500 +1,000	+40%	+$125K	﹤0.01%	725
2023 Q1	$246K	Buy	+2,500	New	+$339K	﹤0.01%	809
2022 Q4	–	Sell	-2,000	Closed	-$280K	–	902
2022 Q3	$280K	Hold	2,000	–	–	﹤0.01%	800
2022 Q2	$270K	Buy	+2,000	New	+$341K	﹤0.01%	816

Other funds holding LABU

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CIBC Private Wealth Group's LABU Position: Q4 2025 in Review

CIBC Private Wealth Group held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q4 2025 at 3,750 shares worth $598K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

CIBC Private Wealth Group first reported a position in LABU in Q2 2022 and has held it in 13 quarters since. The position peaked at $740K in Q3 2024. 40 funds tracked by Wall St. Rank hold LABU as of Q4 2025.

CIBC Private Wealth Group held 3,750 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $598K as of Q4 2025.
CIBC Private Wealth Group left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q4 2025.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #832 holding.
CIBC Private Wealth Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and has held it in 13 quarters since.
CIBC Private Wealth Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $740K in Q3 2024.
40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.